Skip to content

BioRestorative Therapies, Inc.

BRTX · XNAS

CIK 1505497fmd_0VZ3498JVSREC0FKA5PRYBG45WServices · Services-Misc Health & Allied Services, NECTemplate: Standard

Coverage: Jan 01, 2009 to Mar 31, 2026, 65 periods

Income Statement · Annual · Millions · USD
Line itemFY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Total revenues0000000000
Total interest income––––––0110
Cost of revenue0–––––––00
Net interest income–––––(2)0110
Gross profit00–––––000
Research and development32221144710
Compensation and benefits––––––––––
Total operating expenses888932619151216
Operating income(8)(8)(8)(8)(3)(26)(19)(15)(12)(16)
Interest expense00––––––––
Other non-operating income (expense)(1)(1)(5)(6)(9)(18)6531
Income before taxes(9)(9)––––––(9)(14)
Income tax expense––––––––––
Net income from continuing operations––––––––––
Net income(9)(9)(13)(15)(11)(44)(13)(10)(9)(14)
BioRestorative Therapies, Inc. (BRTX) financial statements · FinancialMD